Marshall Wace North America’s Chemours CC Stock Holding History

Marshall Wace North America’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.24M	Buy	+42,488	New	+$1.38M	0.01%	856
2019 Q1	–	Sell	-4,772	Closed	-$135K	–	1583
2018 Q4	$135K	Sell	4,772 -194,578	-98%	-$6.15M	﹤0.01%	1029
2018 Q3	$7.86M	Sell	199,350 -509,953	-72%	-$22.3M	0.05%	243
2018 Q2	$31.5M	Sell	709,303 -53,507	-7%	-$2.66M	0.18%	133
2018 Q1	$37.2M	Buy	+762,810	New	+$38.1M	0.19%	130
2017 Q4	–	Sell	-43,681	Closed	-$2.23M	–	1390
2017 Q3	$2.23M	Sell	43,681 -71,607	-62%	-$3.38M	0.01%	772
2017 Q2	$4.38M	Buy	115,288 +74,457	+182%	+$2.94M	0.03%	533
2017 Q1	$1.59M	Buy	+40,831	New	+$1.23M	0.01%	623

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Marshall Wace North America's CC Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Chemours (CC) in Q3 2021: 42,488 shares worth $1.24M. The stake represents 0.01% of the portfolio and ranks #856 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in CC as recently as Q4 2018.

Marshall Wace North America first reported a position in CC in Q1 2017 and has held it in 8 quarters since. The position peaked at $37.2M in Q1 2018. 461 funds tracked by Wall St. Rank hold CC as of Q3 2021.

Marshall Wace North America held 42,488 shares of Chemours worth $1.24M as of Q3 2021.
Chemours was a new Marshall Wace North America position in Q3 2021.
Chemours made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #856 holding.
Marshall Wace North America first reported a position in Chemours in Q1 2017 and has held it in 8 quarters since.
Marshall Wace North America's Chemours position peaked at $37.2M in Q1 2018.
461 funds tracked by Wall St. Rank held Chemours as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.